All stock lists
Lycia Therapeutics, Inc. (NASDAQ:LYCA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
27.73+2.68 (+10.70%)
Insider Score
––Not scored
LYCA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
LYCA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New LYCA patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to LYCA from public contracts
Source: USAspending.gov
Recently reported changes in LYCA holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing LYCA, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for LYCA. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.